Updated Jul 16, 2026
DURCAN DERMOT MARK has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $2.16M.
Dermot Mark Durcan is a corporate executive known for his role as a Director at Cencora, Inc. His professional background includes experience in the pharmaceutical and healthcare sectors, although specific details about his career history and achievements are not widely documented.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | COR | Cencora, Inc. | P — Open-market purchase | 4.0K | $274.19 | $1.10M |
| 2026-05-28 | COR | Cencora, Inc. | P — Open-market purchase | 4.0K | $266.26 | $1.07M |
| 2026-03-09 | COR | Cencora, Inc. | A — Grant or award | 905 | $359.28 | $325K |
Dermot Mark Durcan is a corporate executive known for his role as a Director at Cencora, Inc. His professional background includes experience in the pharmaceutical and healthcare sectors, although specific details about his career history and achievements are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($2.16M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DURCAN DERMOT MARK profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.